Reviva Pharmaceuticals Holdings Inc Market Cap ($27.55)
Market Cap & Net Worth: Reviva Pharmaceuticals Holdings Inc (RVPHW)
Reviva Pharmaceuticals Holdings Inc market cap. Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPHW) has a market capitalization of $27.55 ($27.55) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32088 globally and #6492 in its home market, demonstrating a -69.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Reviva Pharmaceuticals Holdings Inc's stock price $0.00 by its total outstanding shares 9183 (9.18K). Also see cash flow conversion of Reviva Pharmaceuticals Holdings Inc for how efficiently the company converts equity into cash flow.
Reviva Pharmaceuticals Holdings Inc Market Cap History (2018–2025)
Reviva Pharmaceuticals Holdings Inc market cap history from 2018 to 2025. Data shows change from $3.03K to $27.55 (-48.78% CAGR). Check today's stock price for Reviva Pharmaceuticals Holdings Inc for real-time trading data and today's change.
Reviva Pharmaceuticals Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Reviva Pharmaceuticals Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore RVPHW shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RVPHW by Market Capitalization
Companies near Reviva Pharmaceuticals Holdings Inc in the global market cap rankings as of November 5, 2026. Also see how large is Reviva Pharmaceuticals Holdings Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Reviva Pharmaceuticals Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Reviva Pharmaceuticals Holdings Inc (2018–2025)
Market capitalization of Reviva Pharmaceuticals Holdings Inc from 2018 to today. Between 2018 and today, Reviva Pharmaceuticals Holdings Inc's market cap moved from $3.03K to $ 27.55, with a yearly change of -48.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $27.55 | -98.18% |
| 2024 | $1.51K | -88.50% |
| 2023 | $13.13K | +44.44% |
| 2022 | $9.09K | +182.86% |
| 2021 | $3.21K | -48.15% |
| 2020 | $6.20K | +170.00% |
| 2019 | $2.30K | -24.24% |
| 2018 | $3.03K | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Reviva Pharmaceuticals Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.55 USD |
| MoneyControl | $27.55 USD |
| MarketWatch | $27.55 USD |
| marketcap.company | $27.55 USD |
| Reuters | $27.55 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Reviva Pharmaceuticals Holdings Inc
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, i… Read more